Insulin release in type 2 diabetes mellitus

Area of Science:

• Endocrinology
• Metabolic Research
• Diabetes Pathophysiology

Background:

• Type 2 diabetes is characterized by impaired insulin response, where beta-cells fail to secrete sufficient insulin.
• A subset of normal-weight patients with Type 2 diabetes exhibits normal insulin sensitivity but a significant beta-cell secretory defect.
• The underlying molecular mechanisms driving the impaired insulin response in Type 2 diabetes remain unclear.

Purpose of the Study:

• To investigate the molecular basis of impaired insulin response in Type 2 diabetes.
• To explore the role of glucose metabolism within beta-cells in the context of insulin secretion defects.
• To examine alterations in islet glucose metabolism in animal models relevant to Type 2 diabetes.

Main Methods:

• Utilized two established animal models for Type 2 diabetes: the GK rat and the ob/ob mouse.
• Analyzed key aspects of glucose metabolism within pancreatic islets, including utilization, oxidation, and cycling.
• Assessed the activity of the glycerol phosphate shuttle in islet metabolism.

Main Results:

• In GK rats, observed increased glucose utilization with unchanged glucose oxidation, elevated glucose cycling, and reduced glycerol phosphate shuttle activity.
• In ob/ob mice, identified an increased rate of glucose cycling.
• These metabolic derangements in islets suggest a potential link to impaired stimulus-secretion coupling.

Conclusions:

• Impaired glucose metabolism within pancreatic beta-cells may be a primary defect in Type 2 diabetes.
• Alterations in glucose metabolism, such as increased glucose cycling, could lead to incomplete ATP-sensitive K(+)-channel closure.
• This incomplete channel closure may result in a decreased insulin response, contributing to the pathophysiology of Type 2 diabetes.